Navigation Links
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Date:5/1/2012

s reporting more than one side effect. Most side effects were mild. Late side effects of SABR consisted of radiation pneumonitis in two percent of patients and rib fractures in three percent of patients.  

The study authors conclude that NSCLC patients with potentially operable disease who underwent SABR had an excellent outcome after SABR.  "This finding supports ongoing randomized studies comparing surgery and SABR in patients with operable stage I NSCLC," said Dr. Slotman.

In another presentation, Jeffrey Bradley, M.D., professor of radiation oncology at Washington University in St. Louis, provided an overview of a phase III randomized trial that is now accruing patients and will attempt to compare surgery with stereotactic body radiotherapy (SBRT) more systematically.  SBRT is a term used interchangeably with SABR; both refer to a method of treating a tumor with a carefully shaped and precisely targeted high-energy radiation beam to damage tumor cell DNA and kill the cancer cell. The trial is being jointly sponsored by the American College of Surgeons Oncology Group (ACOSOG) and by the Radiation Therapy Oncology Group (RTOG), two organizations that manage nationwide cancer treatment studies.

"The earlier side-by-side comparisons, such as the study by Dr. Slotman and his colleagues, have suggested that SBRT provides similar overall and cause-specific survival rates compared to surgery," said Dr. Bradley.  "However, these studies use non-randomized data and often compared a relatively healthy population of patients who had surgery with a less healthy, population treated using SBRT.  The ACOSOG/RTOG trial seeks to balance the health of patients in both study arms to determine more definitively whether surgery and SBRT provide similar cure and toxicity rates.  This is a very important study because it will help to define the optimal management of patients with early-stage lung cancer," Dr. Bradley added.

The
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
2. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
3. Retrospective Analysis Explores LYSTEDA®s Ability to Reduce Sleep Interruptions in Women With Cyclic Heavy Menstrual Bleeding
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... to discuss the Company,s Second Quarter 2014 financial ... earnings conference call and webcastWhen: , July ... chairman, president and chief executive officer ...
(Date:7/24/2014)... 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a ... announced its financial results for the second quarter ended June ... , Total revenues of $6.5 million in the second quarter ... in 2013 , Total revenues of $13.3 million for ... 78% over the same period in 2013 , Total ...
(Date:7/24/2014)... LOS ANGELES , July 24, 2014 Many ... what they can do to ensure that their practice will ... dentists purchase the basic supplies they use the most can ... other, and many dentists have recently discovered that purchasing ... and loss. According to successful dentists across ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2
... /PRNewswire/ -- PRA International, a leading Clinical Research ... during the 8th Annual Partnerships in Clinical Trials 2009 to ... Trade Centre in Rotterdam, The Netherlands. PRA operational and ... exhibiting at booth number 32. , On 4 November, PRA,s ...
... Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September 30, 2009. , , ... ... sales ... Product sales from core products(2) $532 ...
Cached Medicine Technology:PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 2Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33
(Date:7/25/2014)... MEDICC announced diplomas went to 1,382 new MDs ... of Havana’s graduation ceremonies that also included graduates of ... 879 international graduates from 28 countries, 20 were ... and hundreds of parents packed the Cuban labor union ... President Ramón Machado Ventura and Minister of Health Roberto ...
(Date:7/25/2014)... the leading pan-European association representing medical oncology professionals, ... Data Protection Regulation [1] could make cancer research ... doctors and cancer patients. , The proposed wording ... patient consent, meaning that researchers would have to ... in order to consult their data or use ...
(Date:7/25/2014)... Mahendra Trivedi and his wife Dahryn ... is Power’ on Saturday, July 26, 2014. People from ... life transforming event as they will get a chance ... days are left for the commencement of this rare ... Masters™ Dahryn Trivedi (his wife) and Alice Branton will ...
(Date:7/25/2014)... 25, 2014 CMS recently has imposed ... for providing inadequate access to prescription drugs. Agency audits ... health and safety of beneficiaries in areas such as ... and CMS is taking quick and firm actions to ... Services webinar, “Avoiding Costly Part D Sanctions: Rx ...
(Date:7/25/2014)... Abilene, Texas (PRWEB) July 25, 2014 Yisrayl ... posted a new article on his blog explaining why so ... are needed the most. , In the article, Yisrayl ... going out and shares the results. For example, in one ... displayed all over church grounds to pray for rain; ironically, ...
Breaking Medicine News(10 mins):Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 2Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 3Health News:Is Europe putting cancer research at risk? 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3
... Nov. 3 Rib-X Pharmaceuticals, Inc.,("Rib-X" or the ... development of novel antibiotics for the treatment of,antibiotic-resistant ... Chief Executive Officer, is scheduled to present at ... Monday, November 10,2008 at 2:00pm EST. The conference ...
... TSX: BMR, TORONTO, Nov. 3 /PRNewswire-FirstCall/ - ... development and,commercialization of cancer therapies, announced today that ... of the Company, will present a,corporate update at ... being held in New York City from November ...
... Most frequent tumor sites were cervix, head and neck, ... -- An estimated 25,000 cases of cancers associated with ... District of Columbia between 1998 and 2003, U.S. officials ... that includes more than 100 different types, more than ...
... study comparing cancer rates of liver transplant patients to ... recipients face increased risks of developing cancer, especially non-Hodgkin,s ... the first year of follow-up and among younger transplant ... of Liver Transplantation , a journal by John ...
... new studies conclude that a review which claimed that homeopathy ... was seriously flawed. , George Lewith, Professor of ... indication of which trials were analysed nor of the various ... scientific practice. If we presume that homeopathy works for some ...
... genetic vulnerability , , MONDAY, Nov. 3 (HealthDay News) ... States that get a lot of precipitation appear to ... study suggests. , Because these children may spend more ... atmosphere to the ground, they might be exposed to ...
Cached Medicine News:Health News:Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3Health News:U.S. Reported 25,000 Cases of HPV-Related Cancers Annually 2Health News:Liver transplant recipients have higher cancer risk 2Health News:New evidence for homeopathy 2Health News:Rainier Spots Show Higher Autism Rates 2Health News:Rainier Spots Show Higher Autism Rates 3Health News:Rainier Spots Show Higher Autism Rates 4
... lens, doctors have to make a trade off ... Now, with the Digital Wide Field lens ... both in one lens. This lens provides ... non-contact lens paired with the higher magnification required ...
... The Stryker Wedge Suture Anchors are titanium ... and styles. The Wedge anchors are simple ... and OR staff. The following sizes and ... Suture, 5.0mm Single Eyelet 2 Sutures, 5.0mm ...
... Suture Anchor is a 3.0mm single loaded ... (PLLA). The anchor barb catches on the ... until it "breaks" free. The small size ... also frequently used in rotator cuff repair ...
... absorbable co-polymer synthesized from all-natural ingredients: ... acid. Unlike the homopolymers in common ... (PLLA) or 100% poly-glycolic acid (PGA), ... crystallinity), meaning that its degradation is ...
Medicine Products: